Abstract Infusion of carnitine has been observed to increase non-oxidative glucose disposal in several studies, but the effect of oral carnitine on glucose disposal in non-diabetic lean versus overweight/obese humans has not been examined
Its half-life of approximately 13 hours means steady-state plasma concentrations build relatively quickly, which partly explains why its 5-week titration can produce GI symptoms even when patients follow the schedule correctly
Carter BZ, Kim TK, Mak DH, Hu W, Pinilla C, Reed JC, Andreeff M
Insurance, affordability, and patient preference steer decisions: those needing maximal weight change and willing to self-manage side effects may choose tirzepatide, whereas patients prioritizing tolerability, proven CV data, or lower cost barriers may prefer semaglutide.